2,4,5-Trimethoxyamphetamine
Chemical compound
2,4,5-Trimethoxyamphetamine | |
---|---|
[[File:|frameless|220px|alt=|]] | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
2,4,5-Trimethoxyamphetamine (TMA-2) is a psychedelic amphetamine of the substituted amphetamine class. It is a structural analog of mescaline and is known for its psychoactive effects.
Chemical Structure and Properties
2,4,5-Trimethoxyamphetamine is a phenethylamine derivative, characterized by the presence of three methoxy groups attached to the benzene ring at the 2, 4, and 5 positions. The chemical formula is C12H19NO3, and it has a molecular weight of 225.29 g/mol.
Pharmacology
TMA-2 acts primarily as a serotonin receptor agonist, particularly at the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects. The compound is known to produce alterations in perception, mood, and cognition, similar to other psychedelics such as LSD and psilocybin.
Effects
The effects of TMA-2 can vary significantly depending on the dose and individual sensitivity. Common effects include visual and auditory hallucinations, altered sense of time, and changes in emotional state. Users may also experience enhanced sensory perception and a feeling of connectedness with their surroundings.
Synthesis
The synthesis of 2,4,5-Trimethoxyamphetamine involves the alkylation of 2,4,5-trimethoxybenzaldehyde with nitroethane, followed by reduction of the resulting nitrostyrene to the corresponding amine. This process requires careful control of reaction conditions to ensure the desired product is obtained.
Legal Status
The legal status of TMA-2 varies by country. In some jurisdictions, it is classified as a controlled substance, making its manufacture, sale, or possession illegal without proper authorization. In others, it may be unscheduled but still subject to regulation under analog laws.
History
TMA-2 was first synthesized by the chemist Alexander Shulgin, who documented its effects in his book PiHKAL: A Chemical Love Story. Shulgin's work in the field of psychedelics has been influential in the study of these compounds and their potential therapeutic applications.
Related Compounds
TMA-2 is part of a family of compounds known as the trimethoxyamphetamines, which also includes 2,4,6-Trimethoxyamphetamine (TMA-6) and 3,4,5-Trimethoxyamphetamine (TMA). These compounds share similar structures and effects but differ in the position of the methoxy groups on the benzene ring.
See Also
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD